Application Sponsors
ANDA 207270 | MAYNE PHARMA INC | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Application Products
001 | TABLET;ORAL | 15MG | 0 | MORPHINE SULFATE | MORPHINE SULFATE |
002 | TABLET;ORAL | 30MG | 0 | MORPHINE SULFATE | MORPHINE SULFATE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2021-06-02 | STANDARD |
Submissions Property Types
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
CDER Filings
MAYNE PHARMA INC
cder:Array
(
[0] => Array
(
[ApplNo] => 207270
[companyName] => MAYNE PHARMA INC
[docInserts] => ["",""]
[products] => [{"drugName":"MORPHINE SULFATE","activeIngredients":"MORPHINE SULFATE","strength":"15MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"MORPHINE SULFATE","activeIngredients":"MORPHINE SULFATE","strength":"30MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"06\/02\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2021-06-02
)
)